InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model Read the entire pressrelease here!

The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies. “The contracts with our new clients clearly show that pharmaceutical companies continue to invest in the development of new drugs for fibrosis, which is extremely promising for InfiCure Bio”, says [...]